Preparing for change - again - with the XEVMPD
This article was originally published in SRA
Executive Summary
The EMA’s update of requirements on submitting data to the extended Eudravigilance medicinal product dictionary brings significant changes. Andrew Marr explains how the newly issued requirements will affect pharmaceutical companies in 2014 and beyond.